{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T02:08:32Z","timestamp":1792375712777,"version":"4.4.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001077","name":"Royal Brisbane and Women's Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001077","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.jneuroim.2015.05.017","type":"journal-article","created":{"date-parts":[[2015,5,20]],"date-time":"2015-05-20T23:07:03Z","timestamp":1432163223000},"page":"53-56","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["The frequencies of Killer immunoglobulin-like receptors and their HLA ligands in chronic inflammatory demyelinating polyradiculoneuropathy are similar to those in Guillian Barre syndrome but differ from those of controls, suggesting a role for NK cells in pathogenesis"],"prefix":"10.1016","volume":"285","author":[{"given":"Stefan","family":"Blum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Csurhes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2704-8517","authenticated-orcid":false,"given":"Pamela","family":"McCombe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2015.05.017_bb0005","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1136\/jnnp.42.2.184","article-title":"HLA antigens in chronic relapsing idiopathic inflammatory polyneuropathy","volume":"42","author":"Adams","year":"1979","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"27 Suppl.","key":"10.1016\/j.jneuroim.2015.05.017_bb0010","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1002\/ana.410270707","article-title":"Assessment of current diagnostic criteria for Guillain\u2013Barr\u00e9 syndrome [see comments]","author":"Asbury","year":"1990","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2015.05.017_bb0015","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/jns5.12074","article-title":"Genetics of Guillain\u2013Barre syndrome (GBS) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): current knowledge and future directions","volume":"19","author":"Blum","year":"2014","journal-title":"J. Peripher. Nerv. Syst."},{"key":"10.1016\/j.jneuroim.2015.05.017_bb0020","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jneuroim.2013.12.007","article-title":"Killer immunoglobulin-like receptor and their HLA ligands in Guillain\u2013Barre Syndrome","volume":"267","author":"Blum","year":"2013","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2015.05.017_bb0025","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/jns5.12045","article-title":"Clinical features of patients with Guillain\u2013Barre syndrome at seven hospitals on the East Coast of Australia","volume":"18","author":"Blum","year":"2013","journal-title":"J. Peripher. Nerv. Syst."},{"key":"10.1016\/j.jneuroim.2015.05.017_bb0030","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/j.1468-1331.2010.03333.x","article-title":"The effect of IgG levels on the number of natural killer cells and their Fc receptors in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"18","author":"Bohn","year":"2011","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jneuroim.2015.05.017_bb0035","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1212\/WNL.52.3.498","article-title":"Clinicopathologic findings and prognosis of chronic inflammatory demyelinating polyneuropathy","volume":"52","author":"Bouchard","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2015.05.017_bb0040","first-page":"225","article-title":"The impact of variation at the KIR gene cluster on human disease","volume":"298","author":"Carrington","year":"2006","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.jneuroim.2015.05.017_bb0045","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1529-8027.2008.00158.x","article-title":"Impairment of circulating CD4+CD25+ regulatory T cells in patients with chronic inflammatory demyelinating polyradiculoneuropathy","volume":"13","author":"Chi","year":"2008","journal-title":"J. Peripher. Nerv. Syst."},{"key":"10.1016\/j.jneuroim.2015.05.017_bb0050","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/j.0022-202X.2005.23856.x","article-title":"Old meets new: the interaction between innate and adaptive immunity","volume":"125","author":"Clark","year":"2005","journal-title":"J. Investig. Dermatol."},{"key":"10.1016\/j.jneuroim.2015.05.017_bb0055","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jocn.2004.04.006","article-title":"Increased circulating T cell reactivity to GM1 ganglioside in patients with Guillain-Barre syndrome","volume":"12","author":"Csurhes","year":"2005","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.jneuroim.2015.05.017_bb0060","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1136\/jnnp.2004.052282","article-title":"T cell reactivity to P0, P2, PMP-22, and myelin basic protein in patients with Guillain\u2013Barre syndrome and chronic inflammatory demyelinating polyradiculoneuropathy","volume":"76","author":"Csurhes","year":"2005","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2015.05.017_bb0065","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/mus.21480","article-title":"Clinical and electrophysiological parameters distinguishing acute-onset chronic inflammatory demyelinating polyneuropathy from acute inflammatory demyelinating polyneuropathy","volume":"41","author":"Dionne","year":"2010","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jneuroim.2015.05.017_bb0070","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/ana.410110205","article-title":"Prednisone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatment","volume":"11","author":"Dyck","year":"1982","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2015.05.017_bb0075","first-page":"CD001797","article-title":"Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy","author":"Eftimov","year":"2009","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jneuroim.2015.05.017_bb0080","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1136\/jnnp.53.2.170","article-title":"HLA antigens in chronic inflammatory demyelinating polyneuropathy","volume":"53","author":"Feeney","year":"1990","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2015.05.017_bb0085","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/gene.2010.9","article-title":"Signatures of natural selection and coevolution between killer cell immunoglobulin-like receptors (KIR) and HLA class I genes","volume":"11","author":"Guinan","year":"2010","journal-title":"Genes Immun."},{"key":"10.1016\/j.jneuroim.2015.05.017_bb0090","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1085-9489.2006.00061.x","article-title":"Pathogenesis of chronic inflammatory demyelinating polyradiculoneuropathy","volume":"11","author":"Hughes","year":"2006","journal-title":"J. Peripher. Nerv. Syst."},{"key":"10.1016\/j.jneuroim.2015.05.017_bb0095","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1093\/brain\/awm004","article-title":"Immunotherapy for Guillain\u2013Barre syndrome: a systematic review","volume":"130","author":"Hughes","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2015.05.017_bb0100","doi-asserted-by":"crossref","first-page":"4375","DOI":"10.4049\/jimmunol.164.8.4375","article-title":"Differential expression of NK T cell V alpha 24 J alpha Q invariant TCR chain in the lesions of multiple sclerosis and chronic inflammatory demyelinating polyneuropathy","volume":"164","author":"Illes","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2015.05.017_bb0105","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1136\/jnnp.2006.106617","article-title":"Antibody responses to peptides of peripheral nerve myelin proteins P0 and P2 in patients with inflammatory demyelinating neuropathy","volume":"78","author":"Inglis","year":"2007","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2015.05.017_bb0110","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1136\/jnnp-2012-302312","article-title":"Biology of the blood\u2013nerve barrier and its alteration in immune mediated neuropathies","volume":"84","author":"Kanda","year":"2013","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2015.05.017_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jns.2008.11.015","article-title":"Derivation and validation of diagnostic criteria for chronic inflammatory demyelinating polyneuropathy","volume":"277","author":"Koski","year":"2009","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2015.05.017_bb0120","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.autrev.2014.08.005","article-title":"Peripheral nerve proteins as potential autoantigens in acute and chronic inflammatory demyelinating polyneuropathies","volume":"13","author":"Lim","year":"2014","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jneuroim.2015.05.017_bb0125","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1093\/brain\/110.6.1617","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy. A clinical and electrophysiological study of 92 cases","volume":"110","author":"McCombe","year":"1987","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2015.05.017_bb0130","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0165-5728(90)90027-K","article-title":"The effects of prophylactic cyclosporin A on experimental allergic neuritis (EAN) in the Lewis rat. Induction of relapsing EAN using low dose cyclosporin A","volume":"28","author":"McCombe","year":"1990","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2015.05.017_bb0135","doi-asserted-by":"crossref","first-page":"667","DOI":"10.3109\/08916930903140907","article-title":"Circulating subsets and CD4(+)CD25(+) regulatory T cell function in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"42","author":"Sanvito","year":"2009","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jneuroim.2015.05.017_bb0140","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1212\/WNL.0b013e318245d250","article-title":"CD8+ T-cell immunity in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"78","author":"Schneider-Hohendorf","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2015.05.017_bb0145","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0165-5728(91)90005-R","article-title":"HLA antigens in patients with chronic inflammatory demyelinating polyneuropathy","volume":"32","author":"van Doorn","year":"1991","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2015.05.017_bb0150","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/ni1582","article-title":"Functions of natural killer cells","volume":"9","author":"Vivier","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jneuroim.2015.05.017_bb0155","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/ana.1129","article-title":"P0 protein is a target antigen in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"50","author":"Yan","year":"2001","journal-title":"Ann. Neurol."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572815001290?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572815001290?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:25:43Z","timestamp":1759047943000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572815001290"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":31,"alternative-id":["S0165572815001290"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2015.05.017","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The frequencies of Killer immunoglobulin-like receptors and their HLA ligands in chronic inflammatory demyelinating polyradiculoneuropathy are similar to those in Guillian Barre syndrome but differ from those of controls, suggesting a role for NK cells in pathogenesis","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2015.05.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}